Clonz Biotech Pvt Ltd

Clonz Biotech Pvt Ltd is a dynamic biopharmaceutical company focused on the development, manufacturing, and commercialization of human therapeutic biosimilar Monoclonal Antibodies (MAbs). Located in Shamirpet, IN, Clonz Biotech Pvt Ltd is dedicated to delivering high-quality biologics to make treatment and care more affordable worldwide, with a strong emphasis on oncology.

Operating as a DSIR (Government of India) recognized R&D unit, Clonz Biotech Pvt Ltd boasts a fully integrated mammalian platform for developing biosimilar MAbs. With experienced leadership and a commitment to innovation, Clonz Biotech Pvt Ltd continues to expand its capabilities through investments in state-of-the-art Drug Substance and Drug Product manufacturing facilities for CDMO. The company is committed to pushing the boundaries of biotechnology research and development.

Under the recent acquisition by Sri Krishna Pharmaceuticals Ltd, Clonz Biotech Pvt Ltd is poised for significant growth and enhanced service offerings. The company’s unwavering focus on quality and affordability positions it as a key player in the global biopharmaceutical landscape. We invite the manager of Clonz Biotech Pvt Ltd to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial development.